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Background. Major depression is often chronic or recurrent and is usually treated within primary care. Little is known about the
associated morbidity and costs. Objectives. To determine socio-demographic characteristics of people with chronic or recurrent
depression in primary care and associated morbidity, service use, and costs. Method. 558 participants were recruited from 42GP
practices in the UK. All participants had a history of chronic major depression, recurrent major depression, or dysthymia.
Participants completed questionnaires including the BDI-II, Work and Social Adjustment Scale, Euroquol, and Client Service
Receipt Inventory documenting use of primary care, mental health, and other services. Results. The sample was characterised by
high levels of depression, functional impairment, and high service use and costs. Themajority (74%) had been treated with an anti-
depressant, while few had seen a counsellor (15%) or a psychologist (3%) in the preceding three months. The group with chronic
major depression was most depressed and impaired with highest service use, whilst those with dysthymia were least depressed,
impaired, and costly to support but still had high morbidity and associated costs. Conclusion. This is a patient group with very
significant morbidity and high costs. Eﬀective interventions to reduce both are required.
1. Introduction
In the UK, clinically significant or major depression aﬀects
between 5% and 10% of people at any time, with most
being treated within general practice [1]. The annual cost
of depression has been estimated to be over £9 billion in
England [2], with more than 100 million working days lost
and over 2,500 deaths due to depression in 2000 [2].
Major depression is often a chronic or recurrent disorder,
with an estimated 80% of people experiencing at least one
recurrence, although one primary care study has reported
recurrence rates as low as 40% after a first episode [3].
Approximately 12% follow a chronic course [4]. Results from
other studies indicate that only 50% of those with major
depression will have recovered at one year [5]. The risk of
recurrence increases with each successive episode [6].
Primary care populations with chronic or recurrent
depression, although clinically important, are rarely investi-
gated as a distinct patient group [7]. Past work has shown
that chronicity is associated with high mortality, greater
psychological and social morbidity, high use of primary care
services [8], and high social and financial costs [3]. However,
we have little detailed information on the specific morbidity,
functional impairment, health service use or costs of chronic
or recurrent depression in primary care settings.
In this study, our aims were to examine socio-
demographic characteristics, morbidity, service use, and
associated costs for three main clinical groups of people
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Recurrent major depression
Recurrent major depression was defined by participants having two or more episodes of major depression within a three-year
period. An episode of major depression must last at least two weeks with a period of recovery lasting at least two months in
between episodes and must interfere with the person’s normal functioning.
Dysthymia
Dysthymia lasts at least two years, with symptoms which are less severe than those of major depression, but which nonetheless
impair the individual’s functioning.
Chronic major depression
An episode of major depression which lasts for a full two year period without a break of two months or more in which the
person could function normally.
Box 1: DSM-IV diagnoses included in the ProCEED study.
with depression. Our sample comprised people looked after
in primary care who were diagnosed with chronic major
depression, recurrent major depression, and dysthymia. We
addressed three main questions as follows.
(1) What were the socio-demographic characteristics
of people in these three groups, and were there
diﬀerences between the groups?
(2) Were there diﬀerences in the associated morbidity?
(3) What services were used by these three groups, and
what were the associated costs?
2. Methods
2.1. Recruitment. A total of 558 participants were recruited
between November 2007 and July 2008 from 42GP practices
in England, Scotland, and Northern Ireland. The aim was to
recruit a representative sample of practices from throughout
the UK, including urban and rural areas and areas with
diverse ethnic populations. Participants were identified to be
part of multi-centre study to test whether regular proactive
contact with a practice nurse would benefit people with
chronic or recurrent depression [9]. Patients were eligible if
they were over the age of 18, had a recent history of chronic
or recurrent major depression or dysthymia based on the
Composite International Diagnostic Interview (CIDI), and
their symptoms indicated at least mild depression (scoring
14 or higher on the Beck Depression Inventory; BDI-II).
Patients with impaired cognitive function, current psychotic
symptoms, or incapacitating drug or alcohol dependence
were excluded. All patients who met eligibility criteria and
who consented to participate were included in the study.
Recruitment procedures, inclusion/exclusion criteria, and
outcome measures used have been fully described elsewhere
[9]. The findings reported here are based on pooled data
collected at baseline from both intervention and control
participants before the intervention began.
2.2. Measures. Prior to enrolment, participants were inter-
viewed by the practice/research nurse to check eligibility.
The nurses had been trained to conduct the recruitment
interview. Research questionnaires were completed by eligi-
ble participants immediately after the interview and prior to
randomisation.
The CIDI was administered by the nurse to check
eligibility. Eligible participants met criteria for one of three
DSM-IV diagnoses as described in Box 1 [10].
The self-report questionnaires completed included
assessment of severity of depressive symptoms using
the BDI-II, a widely used 21-item questionnaire [11].
Functional impairment was measured using the Work
and Social Adjustment Scale (WSAS), a 5-item measure
of impairment attributable to an identified problem (e.g.,
depression) [12]. Service use was assessed using the Client
Service Receipt Inventory (CSRI), a self-complete record of
demographic data, medication, and health and community
service use for the three months prior to recruitment [13].
Cost Calculations. The costs of service use for each person
were calculated by identifying an appropriate unit cost for
each contact and multiplying it by the number of contacts
each person recorded on the CSRI. For most hospital, mental
health and primary care services as well as social service
interventions, unit costs were drawn from publicly available
sources [14, 15]. The remainder was taken from previous
studies or estimated using an equivalent method [16]. Where
the number of service contacts was missing, the mean for the
whole group or aminimum of one contact was used. All costs
are presented in 2008 prices.
2.3. Data Analysis. Descriptive statistics were produced for
socio-demographic characteristics, BDI II and WSAS, by
each diagnostic group. Findings are presented as percentages
for categorical variables and means, and standard deviations
are used for continuous variables as the data were found to
be approximately normally distributed.
The proportion of people using selected services and the
contact rates are reported by diagnostic group. Costs are
compared between diagnostic groups using t-tests with 1,000
bootstrap replications [17] using STATA version 10.0 and
SPSS version 17.0 software.
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Table 1: Socio-demographic and diagnostic characteristics.
Diagnosis
Chronic major depression Recurrent depression Dysthymia Total
Total sample 164 (29.8%) 297 (54%) 89 (16.2%) 550
Diagnosis by gender
Male 51 (31.1%) 57 (19.2%) 31 (34.8%) 139 (25.3%)
Female 113 (68.9%) 240 (80.8%) 58 (65.2%) 411 (74.7%)
Age
Mean (SD) [range] 50 (14) [18–85] 46 (12) [20–63] 52 (13) [23–77] 48 (13) [18–85]
Ethnic group (n = 543)
White 154 (96.3%) 283 (96.0%) 83 (94.3%) 520 (95.8%)
Other 6 (3.1%) 12 (4.0%) 5 (5.7%) 23 (4.2%)
Marital status (n = 546)
Married/cohabiting 86 (53.1%) 160 (54.2%) 59 (66.3%) 305 (55.9%)
Divorced/separated/widowed/single 76 (46.9%) 135 (45.8%) 30 (33.7%) 241 (44.1%)
Living situation (n = 546)
Partner/children 113 (70.2%) 216 (72.7%) 67 (76.1%) 396 (72.5%)
Other 48 (29.8%) 81 (27.3%) 21 (23.9%) 150 (27.5%)
Housing (n = 541)
Owner occupied 103 (64.8%) 196 (66.7%) 64 (72.7%) 363 (67.1%)
Rented/temporary accommodation 56 (35.2%) 98 (33.3%) 24 (27.3%) 178 (32.9%)
Occupation (n = 545)
Paid employment 57 (35.2%) 165 (55.9%) 34 (38.6%) 256 (47.0%)
Long term Sick/retired/homemaker/
unemployed/other
105 (64.8%) 130 (44.1%) 54 (61.4%) 289 (53.0%)
3. Results
3.1. Characteristics of the Sample
3.1.1. Socio-Demographic Characteristics. Table 1 reports the
demographic and diagnostic characteristics of the study
sample; 54% of participants met criteria for recurrent major
depression, 30% for chronic major depression, and 16%
for dysthymia. The average age of the sample was 48 years,
and 75% were female. Two thirds were owner occupiers of
their homes. Just under half were in paid employment. A
greater proportion of those with dysthymia were married
or cohabiting (66%) compared to those with chronic major
depression (53%) or recurrent depression (54%). Over half
of those with recurrent depression were in paid employment
(56%), compared to just 35% of those with chronic major
depression and 39% of those with dysthymia.
3.1.2. Depression and Functional Impairment. Tables 2 and
3 report participants’ scores on measures of depression
and functional impairment by diagnostic group. Higher
scores on the BDI-II and WSAS scales indicate higher
levels of depression and functional impairment. 62% of the
entire sample were categorised as severely depressed [11]
and 61% categorised as moderately or severely functionally
impaired [12]. Those with chronic major depression had
the highest mean BDI II score, and 76% of this group
were severely depressed, compared with 57% of those with
recurrent depression and 54% with dysthymia. Participants
with chronic major depression also had the highest mean
WSAS impairment score with 69% of this group at least
moderately impaired.
3.1.3. Service Use and Costs. Costs were available for 549 par-
ticipants, although we excluded one person who remained
in hospital for the full period as no community or primary
care services were used. Table 4 identifies service use patterns
between the groups, showing in detail the use of GP, practice
nurse, and mental health services and conflating others into
five main categories. In the previous 3 months, 63% of the
chronic major depression group had consulted a GP for
depression, a higher proportion than either the recurrent
depression or dysthymia groups. However, the dysthymia
group had the highest proportion who reported any primary
care consultations for all reasons in the past three months
(89%). A minority of the total sample had seen a counsellor
(15%) or a psychologist (3%).
Across the whole sample, a wide range of services was
used although, with the notable exception of primary care,
most services were only used by one or two people. Very few
people across the whole sample had seen a secondary care
mental health professional, either a psychiatrist (5%) or psy-
chologist (3%), while around a sixth (15%) had had contact
with a practice counsellor. Despite the diﬀerences in severity
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Table 2: Severity of depression by diagnostic group.
Diagnosis
Chronic major depression
(n = 164)
Recurrent depression
(n = 297)
Dysthymia
(n = 89)
Total
(n = 550)
BDI-II total score
Mean (SD) 36.0 (10.7) 31.4 (9.9) 29.76 (8.6) 32.52 (10.2)
Range 14–60 14–57 14–49 14–60
BDI-II depression severity
Mild depression 11 (6.7%) 39 (13.1%) 11 (12.4%) 61 (11.1%)
Moderate depression 29 (17.7%) 88 (29.6%) 30 (33.7%) 147 (26.7%)
Severe depression 124 (75.6%) 170 (57.2%) 48 (53.9%) 342 (62.2%)
Table 3: Severity of functional impairment by diagnostic group.
Diagnosis
Chronic major depression
(n = 163)
Recurrent depression
(n = 296)
Dysthymia
(n = 88)
Total
(n = 547)
WSAS total score
Mean (SD) 24.97 (9.7) 21.41 (9.4) 20.38 (8.4) 22.3 (9.5)
Range 0–40 0–40 3–38 0–40
WSAS impairment severity
Subclinical impairment 11 (6.7%) 40 (13.5%) 10 (11.4%) 61 (11.2%)
Significant impairment 39 (23.9%) 84 (28.4%) 29 (33.0%) 152 (27.8%)
Moderately severe or worse impairment 113 (69.3%) 172 (58.1%) 49 (55.7%) 334 (61.1%)
Table 4: Service use over 3 months, by diagnostic group.
Servicea
Chronic major depression (n = 163) Recurrent depression (n = 296) Dysthymia (n = 89) Total (n = 548)
% using service
Mean number
contacts
% using
service
Mean
number
contacts
% using
service
Mean
number
contacts
% using
service
Mean
number
contacts
GP (depression) 63% 1.16 57% 1.16 58% 1.16 59% 1.16
GP (other reason) 61% 1.38 57% 1.16 67% 1.29 60% 1.25
Practice nurse
(depression)
9% 0.12 5% 0.06 9% 0.12 7% 0.09
Practice nurse (other) 33% 0.51 31% 0.49 28% 0.40 31% 0.49
Any primary care 85% — 88% — 89% — 87% —
Psychiatrist 4% 0.13 5% 0.08 4% 0.07 5% 0.09
Psychologist 7% 0.313 1% 0.033 3% 0.06 3% 0.11
Counsellor 16% 0.932 16% 0.921 9% 0.331 15% 0.82
Any mental health
contacts
28% — 28% — 16% — 26% —
Any hospital services 40% — 35% — 37% — 37% —
Any alternative therapy 7% 0.212 11% 0.781 1% 0.011,2 9% 0.48
Any other health and
community services
26% — 25% — 27% — 26% —
Anti-depressants 80% — 72% — 70% — 74% —
Other medications 77% — 63% — 79% — 70% —
a
Any primary care includes all GP and practice nurse contacts, other primary care services. Any mental health services include psychiatrist, psychologist,
counsellor, psychotherapy, psychiatric community nurse. Any hospital services include inpatient and outpatient services for depression or other reason, A&E
or minor injuries unit. Any alternative therapy includes, for example, hydrotherapy, spiritual healing. Any other health and community services include
community health services, social work and other social care, self-help and support services, support provided by the voluntary sector.
1Significant diﬀerence between dysthymia and recurrent depression groups.
2Significant diﬀerence between dysthymia and chronic major depression groups.
3Significant diﬀerence between recurrent depression and chronic major depression groups.
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Table 5: Average costs over three months, by service category and diagnostic group.
Service categorya
Chronic major
depression (n = 163)
Recurrent depression
(n = 296) Dysthymia (n = 89) Total (n = 548)
Mean costs (SD) Mean costs (SD) Mean costs (SD) Mean costs (SD)
Primary care £96 (80) £88 (77) £92 (67) 91 (77)
Mental health £1472 (401) £1071 (317) £401,2 (136) 105 (325)
Hospital £176 (463) £154 (520) £107 (230) 153 (467)
Alternative therapy £92,3 (48) £331,3 (235) £01,2 (4) 21 (175)
Other health and community
services
£67 (232) £54 (213) £57 (218) 58 (219)
Anti-depressants £12 (20) £12 (21) £11 (19) 12 (20)
Other medications £173 (13) £121,3 (14) £151 (15) 14 (15)
Total costs £5232 (784) £4601 (787) £3221,2 (386) 457 (738)
a
See Table 4 for services included in each category.
1Significant diﬀerence between dysthymia and recurrent depression groups.
2Significant diﬀerence between dysthymia and chronic major depression groups.
3Significant diﬀerence between recurrent depression and chronic major depression groups.
of depression and levels of functional impairment, a similar
proportion of people in each of the three groups had used
each of the services with two exceptions. Table 4 shows that,
compared to the other groups, those with dysthymia were
less likely to be in contact with any mental health services
and a higher proportion those with recurrent depression had
seen an alternative (complementary) therapist.
The majority of the sample (74%) had been prescribed
anti-depressant medication in the previous 3 months,
including 80% of those with chronic major depression, 72%
of those with recurrent depression, and 70% with dysthymia.
Anti-depressants were by far the most commonly prescribed
medication in this population.
Table 5 shows the costs of support for each diagnostic
group over the 3-month period. Hospital costs account for
the highest proportion of total costs for the total sample
and also within each diagnostic group (around a third),
followed by primary care and mental health services. Cost
diﬀerences between groups generally reflect the service use
patterns (Table 4). Average costs for primary care and other
health and community services were similar in each group.
Bootstrapped t-tests found significantly higher mean
costs for the recurrent depression and chronic major
depression groups compared to those with dysthymia for
mental health services, alternative therapy, and total costs.
Those with recurrent depression also had higher costs for
alternative therapy and significantly lower costs for “other
medications” than those with chronic major depression.
4. Discussion
Three groups were identified among this sample of primary
care patients based on the DSM-IV diagnostic criteria for
chronic major depression, recurrent depression, or dys-
thymia. The sample as a whole was characterised by very high
levels of depressive symptoms and functional impairment,
and the majority had been prescribed anti-depressants in
the preceding three months. Those with chronic major
depression were the most depressed and impaired of the
three groups. Compared to the other two groups, they had
the highest costs for mental health service use and the costs
for their full service package were also highest (final row,
Table 5). People with dysthymia were the least depressed and
had less severe functional impairment; their total service
costs were lowest, as was the proportion in contact with
mental health services.
All three groups made considerable use of GPs, with on
average slightly more than one GP consultation for depres-
sion and more than one consultation for other reasons in the
previous three months. If the threemonths prior to interview
are representative of the full year, these suggest higher contact
rates than in the population as a whole. National data show
women have an average of five GP appointments per year for
all reasons and men have four [18].
Levels of depression were much higher among our
sample than reported in another primary care study of
recurrent depression which used the BDI-II as an outcome
measure [7], but this may be due to the eligibility criterion
for this study (above 14 on the BDI-II) which was intended
to ensure inclusion of those with at least minor depression
at the point of recruitment. However, our findings support
previous research showing reductions in functioning and
well-being for depressed patients that equal or exceed those
of patients with other chronic illnesses [19].
The percentage of participants in paid employment was
lower than reported in other studies of primary care patients
with depression [20], reflecting the greater impairment likely
to be associated with chronic or recurrent depression. In
line with other findings, the participants with chronic major
depression were least likely to be in paid employment. In
our sample, men reported significantly higher functional
impairment than women, but the severity of their depression
was similar. Notably, more than three-quarters of partici-
pants had received a prescription for anti-depressants within
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the past three months, but most continued to have very high
levels of depression and associated functional impairment,
which suggests that anti-depressant therapy is far from
optimal in this group. Around a quarter had seen a mental
health professional in the past three months, but most of
these contacts were with a counsellor.
A limitation of this study is that participants were
specifically recruited for a research study and may not
therefore be representative of the whole population of
people with chronic or recurrent depression in primary
care. There were fewer GP practices from inner city areas
participating in the study, and our sample therefore under-
represents populations from these areas. This may aﬀect
the generalisability of our findings to more ethnically and
socially diverse inner city populations. Nonetheless, our
large study sample comprises a rigorously selected group
of patients and indicates the high levels of morbidity
and functional impairment associated with chronic major
depression, recurrent major depression, and dysthymia,
as well as the diﬀerences between these three diagnostic
groups.
People with chronic/recurrent major depression and
dysthymia form clinically important patient groups for
primary care practitioners. Nearly two-thirds of our sam-
ple had severe depressive symptoms and high functional
impairment, despite the majority receiving anti-depressant
treatment. Most were being treated entirely in a primary
care setting where regular followup and review may be
lacking [21, 22]. The chronic nature of their problems and
high rates of attendance in primary care suggests they are
particularly challenging for GPs to work with. Moreover, one
in four of those in our study with chronic major or recurrent
depression had also seen a mental health professional, at least
one in three of the whole sample had attended a hospital-
based service, and one in four had contact with at least
one other health or community care service during the
three months prior to the start of the main study. Further
data collected prospectively for this sample within the over-
arching trial will allow us to test whether a structured
proactive practice nurse-led intervention is an eﬀective form
of intervention for this group.
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